[go: up one dir, main page]

PA8471301A1 - Compuestos azapoliciclicos condensados con arilo - Google Patents

Compuestos azapoliciclicos condensados con arilo

Info

Publication number
PA8471301A1
PA8471301A1 PA19998471301A PA8471301A PA8471301A1 PA 8471301 A1 PA8471301 A1 PA 8471301A1 PA 19998471301 A PA19998471301 A PA 19998471301A PA 8471301 A PA8471301 A PA 8471301A PA 8471301 A1 PA8471301 A1 PA 8471301A1
Authority
PA
Panama
Prior art keywords
compounds
azapolyclic
condensed
aryl
neurological
Prior art date
Application number
PA19998471301A
Other languages
English (en)
Inventor
Jotham Wadsworth Coe
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8471301A1 publication Critical patent/PA8471301A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

SE REIVINDICAN COMPUESTOS DE LA FORMULA (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, EN LA QUE R1, R2, R3 Y Z SE DEFINEN COMO EN LA MEMORIA DESCRIPTIVA, INTERMEDIOS EN LA SINTESIS DE TALES COMPUESTOS , COMPOSICIONES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS Y PROCEDIMIENTOS PARA USAR TALES COMPUESTOS EN EL TRATAMIENTO DE TRASTORNOS NEUROLOGICOS Y PSICOLOGICOS.
PA19998471301A 1998-04-29 1999-04-29 Compuestos azapoliciclicos condensados con arilo PA8471301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8355698P 1998-04-29 1998-04-29

Publications (1)

Publication Number Publication Date
PA8471301A1 true PA8471301A1 (es) 2000-09-29

Family

ID=22179102

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19998471301A PA8471301A1 (es) 1998-04-29 1999-04-29 Compuestos azapoliciclicos condensados con arilo

Country Status (41)

Country Link
US (3) US6462035B1 (es)
EP (1) EP1076650B1 (es)
JP (1) JP2002513007A (es)
KR (1) KR100420423B1 (es)
CN (1) CN1144787C (es)
AP (1) AP1154A (es)
AR (1) AR018596A1 (es)
AT (1) ATE258921T1 (es)
AU (1) AU749831B2 (es)
BG (1) BG64556B1 (es)
BR (1) BR9910058A (es)
CA (1) CA2330576A1 (es)
CO (1) CO5021124A1 (es)
DE (1) DE69914594T2 (es)
DK (1) DK1076650T3 (es)
DZ (1) DZ2778A1 (es)
EA (1) EA003669B1 (es)
ES (1) ES2213354T3 (es)
GT (1) GT199900059A (es)
HR (1) HRP20000731A2 (es)
HU (1) HUP0103340A3 (es)
ID (1) ID26700A (es)
IL (1) IL138917A0 (es)
IS (1) IS5649A (es)
MA (1) MA26623A1 (es)
MY (1) MY133474A (es)
NO (1) NO317300B1 (es)
NZ (1) NZ507035A (es)
OA (1) OA11506A (es)
PA (1) PA8471301A1 (es)
PE (1) PE20000435A1 (es)
PL (1) PL344010A1 (es)
PT (1) PT1076650E (es)
SK (1) SK15952000A3 (es)
TN (1) TNSN99080A1 (es)
TR (1) TR200003122T2 (es)
UA (1) UA61991C2 (es)
UY (1) UY25636A1 (es)
WO (1) WO1999055680A1 (es)
YU (1) YU64400A (es)
ZA (1) ZA992971B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME00459B (me) * 1997-12-31 2011-10-10 Pfizer Prod Inc Aril fuzirana azapoliciklična jedinjenja
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
US20010036943A1 (en) * 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
YU78303A (sh) * 2001-04-20 2006-05-25 Pfizer Products Inc. Postupak za dobijanje 1,3-supstituisanih indena i azapolicikličnih jedinjenja sa pripojenim arilom
SK1912004A3 (en) * 2001-10-31 2004-09-08 Pfizer Prod Inc Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
RU2004116320A (ru) 2001-11-30 2005-10-10 Пфайзер Продактс Инк. (Us) Арилконденсированные азаполициклические соединения
AU2003233228A1 (en) * 2002-05-03 2003-11-17 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolyl-cis/trans-isomerases
US20040224963A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US20040224962A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
JP2006528170A (ja) * 2003-07-21 2006-12-14 ファイザー・プロダクツ・インク アリール縮合型アザ多環式化合物
EP1648893B1 (en) * 2003-07-21 2009-09-23 Pfizer Products Inc. Nicotine addiction reducing heteroaryl fused azapolycyclic compounds
US20050043407A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
CA2591330A1 (en) * 2004-12-07 2006-06-15 Pfizer Products Inc. 1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta [a] inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulatingcholinergic function and in the treatment of addictive disorders
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
DE102005061426A1 (de) * 2005-12-22 2007-07-05 Grünenthal GmbH Substituierte tricyclische Piperidon-Derivate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687937A (en) * 1970-06-23 1972-08-29 Us Of America The 1,5-methano-3-benzazocine derivatives
JPS4914473A (es) * 1972-06-09 1974-02-07
JPS4924968A (es) * 1972-07-01 1974-03-05

Also Published As

Publication number Publication date
DE69914594D1 (de) 2004-03-11
NO20005397D0 (no) 2000-10-26
AP1154A (en) 2003-03-27
TR200003122T2 (tr) 2001-03-21
SK15952000A3 (sk) 2002-06-04
UA61991C2 (en) 2003-12-15
YU64400A (sh) 2003-01-31
BG104983A (en) 2001-09-28
CA2330576A1 (en) 1999-11-04
EP1076650B1 (en) 2004-02-04
US6462035B1 (en) 2002-10-08
UY25636A1 (es) 2000-02-23
ATE258921T1 (de) 2004-02-15
CN1144787C (zh) 2004-04-07
PT1076650E (pt) 2004-05-31
KR100420423B1 (ko) 2004-03-04
OA11506A (en) 2004-05-14
US20030008890A1 (en) 2003-01-09
US7122534B2 (en) 2006-10-17
WO1999055680A1 (en) 1999-11-04
DE69914594T2 (de) 2004-12-09
IL138917A0 (en) 2001-11-25
EP1076650A1 (en) 2001-02-21
KR20010043143A (ko) 2001-05-25
DZ2778A1 (fr) 2005-04-23
DK1076650T3 (da) 2004-05-24
GT199900059A (es) 2000-10-11
NZ507035A (en) 2003-05-30
EA200000996A1 (ru) 2001-06-25
MA26623A1 (fr) 2004-12-20
HUP0103340A2 (hu) 2002-02-28
BG64556B1 (bg) 2005-07-29
IS5649A (is) 2000-09-29
CO5021124A1 (es) 2001-03-27
HUP0103340A3 (en) 2002-10-28
PL344010A1 (en) 2001-09-24
US6706702B2 (en) 2004-03-16
MY133474A (en) 2007-11-30
AP9901524A0 (en) 1999-06-30
PE20000435A1 (es) 2000-05-26
EA003669B1 (ru) 2003-08-28
US20040167149A1 (en) 2004-08-26
AU2951699A (en) 1999-11-16
TNSN99080A1 (fr) 2005-11-10
AU749831B2 (en) 2002-07-04
NO317300B1 (no) 2004-10-04
ZA992971B (en) 2000-10-30
JP2002513007A (ja) 2002-05-08
BR9910058A (pt) 2000-12-26
ID26700A (id) 2001-02-01
HRP20000731A2 (en) 2001-06-30
NO20005397L (no) 2000-10-26
AR018596A1 (es) 2001-11-28
CN1298394A (zh) 2001-06-06
ES2213354T3 (es) 2004-08-16
HK1036453A1 (en) 2002-01-04

Similar Documents

Publication Publication Date Title
PA8463901A1 (es) Compuestos azapoliciclicos condensados con arilo
PA8471301A1 (es) Compuestos azapoliciclicos condensados con arilo
UY27427A1 (es) Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos
ES2161290T3 (es) Derivados de quinazolina.
UY26086A1 (es) Procedimientos e intermedios para preparar compuestos anticancerosos
AR007118A1 (es) 4(3h)-quinazolinonas 2,3 disustituidas y composiciones farmaceuticas que las contienen
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
PA8493701A1 (es) Compuestos para tratar la obesidad
CO5700824A2 (es) Nuevos compuestos heterociclicos utiles para el tratamiento de desordenes inflamatorios y alergicos: proceso para su preparacion y composiciones farmaceuticas que los contienen
UY28103A1 (es) Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
CR20120009A (es) 2-indolinonas sustituidas con pirrolos inhibidores de proteinquinasas (divisional exp. 6728)
PA8569301A1 (es) "derivados de bencimidazol n3 alquilado como inhibidores de mek" "n3 alkylated benzimidazole derivatives as mek inhibitors"
BR0108610A (pt) Compostos azapolicìclicos condensados com arila
AR038045A1 (es) Agentes terapeuticos
PA8436201A1 (es) Derivados 6,5-heterobiciclicos sustituidos
UY28150A1 (es) Agentes terapeuticos
SV1999000251A (es) Derivados de 3,3-biarilpiperidina y 2,2-biarilmorfolina ref. pcl0085/82805/bb
NO20005237D0 (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
BRPI0418181A (pt) emprego de 2-aminotetralinas substituìdas para prevenção do tratamento de morbus parkinson
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
ES2190486T3 (es) 3-acetidinilalquilpiperidinas o -pirrolidinas como antagonistas de la taquicinina.
PA8487701A1 (es) Derivados de 3,3-biarilpiperidina y 2,2-biarilmorfolina
UY26298A1 (es) "derivados de bencimidazol sustituidos con aminocarbonilo, procedimientos para su preparación y su utilización como medicamentos."
SE9702563D0 (sv) Compounds
UY27998A1 (es) Piperazinas sustituidas sustituidas heterocíclicas para el tratamiento de la esquizofrenia